Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1995 Jul;71(837):393–396. doi: 10.1136/pgmj.71.837.393

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

C Bleasdale 1, B Jones 1
PMCID: PMC2397979  PMID: 7567729

Abstract

Non-small cell lung cancer is a major cause of mortality and significant morbidity in the UK. The majority of patients are inoperable and the optimum management of these patients requires a multidisciplinary approach involving the cooperation of respiratory physicians, thoracic surgeons and clinical oncologists (radiotherapists). Treatment techniques are constantly being refined and new approaches developed.

Full text

PDF
393

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. G., Minsky B. D. Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev. 1989 Dec;16(4):247–255. doi: 10.1016/0305-7372(89)90044-3. [DOI] [PubMed] [Google Scholar]
  2. Arriagada R., Le Chevalier T., Quoix E., Ruffie P., de Cremoux H., Douillard J. Y., Tarayre M., Pignon J. P., Laplanche A. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists. Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1183–1190. doi: 10.1016/0360-3016(91)90226-t. [DOI] [PubMed] [Google Scholar]
  3. Burt P. A., O'Driscoll B. R., Notley H. M., Barber P. V., Stout R. Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron. Thorax. 1990 Oct;45(10):765–768. doi: 10.1136/thx.45.10.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carroll M., Morgan S. A., Yarnold J. R., Hill J. M., Wright N. M. Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer. Eur J Cancer Clin Oncol. 1986 Nov;22(11):1353–1356. doi: 10.1016/0277-5379(86)90144-6. [DOI] [PubMed] [Google Scholar]
  5. Flickinger J. C., Kondziolka D., Lunsford L. D., Coffey R. J., Goodman M. L., Shaw E. G., Hudgins W. R., Weiner R., Harsh G. R., 4th, Sneed P. K. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):797–802. doi: 10.1016/0360-3016(94)90098-1. [DOI] [PubMed] [Google Scholar]
  6. Grilli R., Oxman A. D., Julian J. A. Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough? J Clin Oncol. 1993 Oct;11(10):1866–1872. doi: 10.1200/JCO.1993.11.10.1866. [DOI] [PubMed] [Google Scholar]
  7. Hetzel M. R., Smith S. G. Endoscopic palliation of tracheobronchial malignancies. Thorax. 1991 May;46(5):325–333. doi: 10.1136/thx.46.5.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hoffmann T. H., Ransdell H. T. Comparison of lobectomy and wedge resection for carcinoma of the lung. J Thorac Cardiovasc Surg. 1980 Feb;79(2):211–217. [PubMed] [Google Scholar]
  9. Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer. 1991 Feb;63(2):265–270. doi: 10.1038/bjc.1991.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mehta M. P., Shahabi S., Jarjour N. N., Kinsella T. J. Endobronchial irradiation for malignant airway obstruction. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):847–851. doi: 10.1016/0360-3016(89)90077-1. [DOI] [PubMed] [Google Scholar]
  11. Payne D. G. Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy? J Clin Oncol. 1988 Mar;6(3):552–558. doi: 10.1200/JCO.1988.6.3.552. [DOI] [PubMed] [Google Scholar]
  12. Perez C. A., Presant C. A., Van Amburg A. L., 3rd Management of superior vena cava syndrome. Semin Oncol. 1978 Jun;5(2):123–134. [PubMed] [Google Scholar]
  13. Perez C. A., Stanley K., Rubin P., Kramer S., Brady L. W., Marks J. E., Perez-Tamayo R., Brown G. S., Concannon J. P., Rotman M. Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1980 Aug;6(8):987–994. doi: 10.1016/0360-3016(80)90106-6. [DOI] [PubMed] [Google Scholar]
  14. Price P., Hoskin P. J., Easton D., Austin D., Palmer S. G., Yarnold J. R. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986 Aug;6(4):247–255. doi: 10.1016/s0167-8140(86)80191-8. [DOI] [PubMed] [Google Scholar]
  15. Saunders M. I., Bennett M. H., Dische S., Anderson P. J. Primary tumor control after radiotherapy for carcinoma of the bronchus. Int J Radiat Oncol Biol Phys. 1984 Apr;10(4):499–501. doi: 10.1016/0360-3016(84)90029-4. [DOI] [PubMed] [Google Scholar]
  16. Saunders M. I., Dische S., Grosch E. J., Fermont D. C., Ashford R. F., Maher E. J., Makepeace A. R. Experience with CHART. Int J Radiat Oncol Biol Phys. 1991 Aug;21(3):871–878. doi: 10.1016/0360-3016(91)90722-g. [DOI] [PubMed] [Google Scholar]
  17. Speiser B. L. High dose rate brachytherapy of lung cancer: cure or palliation. Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):781–782. doi: 10.1016/0360-3016(94)90208-9. [DOI] [PubMed] [Google Scholar]
  18. Speiser B. L., Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys. 1993 Mar 15;25(4):579–587. doi: 10.1016/0360-3016(93)90002-d. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES